Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of disease

Funding The present work received support from Janssen-Cilag Farmacêutica, Lda, as an Unrestricted Grant. Janssen-Cilag had no role in the execution of the study, including analyses and interpretation of results.

Detalhes bibliográficos
Autor principal:	Sousa, Rute Dinis (author)
Outros Autores:	Gouveia, Miguel (author), Nunes da Silva, Catarina (author), Rodrigues, Ana Maria (author), Cardoso, Graça (author), Antunes, Ana Filipa (author), Canhao, Helena (author), de Almeida, José Miguel Caldas (author)
Formato:	article
Idioma:	eng
Publicado em:	2022
Assuntos:	burden of disease cost of illness disability-adjusted life years (DALYs) lost major depression with suicide risk treatment-resistant depression SDG 3 - Good Health and Well-being
Texto completo:	http://hdl.handle.net/10362/143631
País:	Portugal
Oai:	oai:run.unl.pt:10362/143631

Descrição
Resumo:	Funding The present work received support from Janssen-Cilag Farmacêutica, Lda, as an Unrestricted Grant. Janssen-Cilag had no role in the execution of the study, including analyses and interpretation of results.